Terms: = Germ cell tumor AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
52 results:
1. A prognostic biomarker nrg1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mTOR pathway.
Lin JZ; Lin N; Zhao WJ
J Cell Biochem; 2023 Sep; 124(9):1273-1288. PubMed ID: 37450666
[TBL] [Abstract] [Full Text] [Related]
2. Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway.
Alver TN; Heintz KM; Hovig E; Bøe SL
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1736. PubMed ID: 36251678
[TBL] [Abstract] [Full Text] [Related]
3. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
Akçay S; Güven E; Afzal M; Kazmi I
Gene; 2022 May; 824():146395. PubMed ID: 35283227
[TBL] [Abstract] [Full Text] [Related]
4. Neuregulin-1 regulates the conversion of M1/M2 microglia phenotype via ErbB4-dependent inhibition of the NF-κB pathway.
Ma Y; Fan P; Zhao R; Zhang Y; Wang X; Cui W
Mol Biol Rep; 2022 May; 49(5):3975-3986. PubMed ID: 35166983
[TBL] [Abstract] [Full Text] [Related]
5. Neuregulin 2 (NRG2) is expressed in gliomas and promotes migration of human glioma cells.
Zhao WJ; Yi SJ; Ou GY; Qiao XY
Folia Neuropathol; 2021; 59(2):189-197. PubMed ID: 34284546
[TBL] [Abstract] [Full Text] [Related]
6. Integrative Analysis of Neuregulin Family Members-Related tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract] [Full Text] [Related]
7. Genetic alteration of Chinese patients with rectal mucosal melanoma.
Li H; Yang L; Lai Y; Wang X; Han X; Liu S; Wang D; Li X; Hu N; Kong Y; Si L; Li Z
BMC Cancer; 2021 May; 21(1):623. PubMed ID: 34044811
[TBL] [Abstract] [Full Text] [Related]
8. Neuregulin 1/ErbB4/Akt signaling attenuates cytotoxicity mediated by the APP-CT31 fragment of amyloid precursor protein.
Yoo JY; Kim HB; Baik TK; Lee JH; Woo RS
Exp Mol Pathol; 2021 Jun; 120():104622. PubMed ID: 33684392
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
[TBL] [Abstract] [Full Text] [Related]
10. Characteristics, survival and incidence rates and trends of pilocytic astrocytoma in children in the United States; SEER-based analysis.
Tabash MA
J Neurol Sci; 2019 May; 400():148-152. PubMed ID: 30953904
[TBL] [Abstract] [Full Text] [Related]
11. A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.
Karlsson A; Cirenajwis H; Ericson-Lindquist K; Brunnström H; Reuterswärd C; Jönsson M; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Micke P; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Sci Rep; 2019 Mar; 9(1):5207. PubMed ID: 30914778
[TBL] [Abstract] [Full Text] [Related]
12. ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Capparelli C; Purwin TJ; Heilman SA; Chervoneva I; McCue PA; Berger AC; Davies MA; Gershenwald JE; Krepler C; Aplin AE
Cancer Res; 2018 Oct; 78(19):5680-5693. PubMed ID: 30115691
[TBL] [Abstract] [Full Text] [Related]
13. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
von Achenbach C; Weller M; Szabo E
J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
Jones DC; Scanteianu A; DiStefano M; Bouhaddou M; Birtwistle MR
PLoS One; 2018; 13(1):e0190664. PubMed ID: 29342193
[TBL] [Abstract] [Full Text] [Related]
15. Is it sufficient to repeat LINEAR accelerator stereotactic radiosurgery in choroidal melanoma?
Furdova A; Horkovicova K; Justusova P; Sramka M
Bratisl Lek Listy; 2016; 117(8):456-62. PubMed ID: 27546698
[TBL] [Abstract] [Full Text] [Related]
16. MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand nrg1-beta in melanoma.
Alver TN; Lavelle TJ; Longva AS; Øy GF; Hovig E; Bøe SL
Oncotarget; 2016 Aug; 7(34):55128-55140. PubMed ID: 27391157
[TBL] [Abstract] [Full Text] [Related]
17. Retrospective study of choroidal melanomas at the 1(st) Department of Ophthalmology, AHEPA hospital, Thessaloniki, from 2002 to 2011.
Chranioti AA; Malamas AA; Diavati O; Ziakas NG; Maloutas SG; Oikonomidis PK
Indian J Cancer; 2016; 53(1):190-2. PubMed ID: 27146776
[TBL] [Abstract] [Full Text] [Related]
18. NODULAR POSTERIOR SCLERITIS: Clinico-Sonographic Characteristics and Proposed Diagnostic Criteria.
Agrawal R; Lavric A; Restori M; Pavesio C; Sagoo MS
Retina; 2016 Feb; 36(2):392-401. PubMed ID: 26296144
[TBL] [Abstract] [Full Text] [Related]
19. Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanoma.
Capparelli C; Rosenbaum S; Berger AC; Aplin AE
J Biol Chem; 2015 Oct; 290(40):24267-77. PubMed ID: 26269601
[TBL] [Abstract] [Full Text] [Related]
20. ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.
Capparelli C; Rosenbaum S; Berman-Booty LD; Salhi A; Gaborit N; Zhan T; Chervoneva I; Roszik J; Woodman SE; Davies MA; Setiady YY; Osman I; Yarden Y; Aplin AE
Cancer Res; 2015 Sep; 75(17):3554-67. PubMed ID: 26206558
[TBL] [Abstract] [Full Text] [Related]
[Next]
